Andrea Marcellusi

Assistant Professort

University of Milan

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Public Health Public Health professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrea Marcellusi is an Assistant Professor at the University of Milan, Italy. His research focuses on health economics, specifically in relation to HPV vaccination, Hepatitis C elimination strategies, and the economic impact of various treatments in oncology. Recent publications include analyses of the economic consequences of anti-HCV treatments and studies on the social costs of diseases such as breast cancer. He aims to optimize healthcare resources and improve public health outcomes through his work.

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Marco Trabucco Aurilio

ITALY

View details

Francesco Di Maddaloni

Lecturer

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrea Marcellusi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost

An Analysis of the Social and Economic Costs of Breast Cancer in Italy

Cross-regional variations of Covid-19 mortality in Italy: an ecological study

Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis.

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation.

One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices.

Drug Prices and Value of Oncology Drugs in Italy.

Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data.

[Economic burden of diabetic patients with established atherosclerotic cardiovascular disease or risk factors for atherosclerotic cardiovascular disease.]

Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks' Glecaprevir/Pibrentasvir Therapy.

Collaborators (2)

Marco Trabucco Aurilio

Francesco Di Maddaloni

Make your next move.